{"id":4922,"date":"2018-03-12T15:25:48","date_gmt":"2018-03-12T22:25:48","guid":{"rendered":"http:\/\/www.acsr1.com\/?p=4922"},"modified":"2026-07-09T15:00:47","modified_gmt":"2026-07-09T22:00:47","slug":"kaposis-sarcoma-associated-herpesvirus-kshv-transmission-rfa","status":"publish","type":"post","link":"https:\/\/www.acsr1.com\/?p=4922","title":{"rendered":"Kaposi’s Sarcoma-Associated Herpesvirus Transmission RFA"},"content":{"rendered":"
\n
\n\t\t\"ACSR\n\t<\/div>\n\n<\/div><\/div><\/div>

KSHV Transmission RFA<\/h3>\n
\n\t

For more information about this potential funding opportunity, please check out the Office of HIV and AIDS Malignancy's presentation of the FOA Concept to the Board of Scientific Advisors on November 29th, 2017.<\/p>\n

Application Deadline: August 16, 2018, 5:00 PM\u00a0(EDT)<\/strong><\/p>\n

(READ MORE: R21<\/a> and R01<\/a>)<\/strong><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

For more information about this potential funding opportunity, please check out the Office of HIV and AIDS Malignancy’s presentation of the FOA Concept to the Board of Scientific Advisors on …<\/p>\n","protected":false},"author":22,"featured_media":3759,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false},"categories":[23,34],"tags":[18,27,45,63,64],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t